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It is estimated that more than 14.5 million peo-
ple in the contiguous United States live within
1 mi of at least one Superfund site (Heitgerd
and Lee 2003). Common contaminants at
these sites include heavy metals, volatile
organic compounds, and chlorinated hydro-
carbons. Many of these substances are present
at elevated levels, with the potential for on-site
and off-site human contact (Heitgerd and Lee
2003). Residents living in communities near
Superfund sites have expressed concern that
these releases affect their health, including
adverse effects on their immune systems. These
concerns have been difﬁcult to address because
the available epidemiologic studies regarding
immunologic end points are based on occupa-
tionally exposed workers or accidentally
exposed cohorts exposed to high levels of envi-
ronmental contaminants (Tryphonas 2001).
To evaluate the potential effect of environ-
mental toxicants on the immune system of
residents in communities located near haz-
ardous waste sites, the U.S. Agency for Toxic
Substances and Disease Registry (ATSDR)
developed an immune test battery for inclu-
sion in community health studies (ATSDR
1994a). This test battery was proposed as a
general evaluation of immune status to be
used when there was no clear indication of
particular health effects or well-deﬁned expo-
sures (Vogt 1991). The basic immune test
battery consists of lymphocyte ﬂow cytometric
immunophenotyping with speciﬁc cluster des-
ignation antibody reagents to identify the
major types of lymphocytes (CD4 lymphocyte
count, CD8 lymphocyte count, CD4:CD8
ratio, T cells, and B cells) and quantitative lev-
els of immunoglobulins (IgA, IgG, and IgM).
The tests included in this panel were chosen
to assess immune dysfunction in conjunction
with self-reported symptoms and illnesses
relating to these conditions.
The biomarker panel was applied in several
ATSDR cross-sectional health investigations.
However, the interpretation of the immuno-
globulin values was difficult because of the
wide biological variability within populations,
nonspecific nature of the tests, and lack of
established reference ranges for these tests. In
1998, the Foundation for Blood Research in
Scarborough, Maine, provided age- and sex-
speciﬁc reference limits for IgA, IgG, and IgM
(Ritchie et al. 1998). These reference limits
were based on automated immunoassay values
from 115,017 serum samples, which represents
the largest study population in North America
obtained within a single laboratory.
The purpose of this study was to reevaluate
immunoglobulin levels collected over several
investigations by using a consistent approach
to data analysis to determine whether individu-
als who live near several Superfund sites are
more likely to have test results below or above
the reference range  than individuals who live
in comparison areas with no Superfund site.
Other factors that may be potential con-
founders or modiﬁers of these associations are
examined as well.
Materials and Methods
Study areas. We used data from six cross-
sectional studies conducted by the ATSDR
between 1991 and 1994 for this analysis. These
studies were conducted in Kentucky (ATSDR
1995b), Texas (ATSDR 1995d), California
(ATSDR 1996b), Nebraska (ATSDR 1996c),
Massachusetts (ATSDR 1998a), and North
Carolina (ATSDR 1998b). Table 1 lists the
study areas, types of facilities, potential expo-
sure pathways, and contaminants of concern.
All six studies were approved by the Centers for
Disease Control and Prevention Institutional
Review Board. Study participants in all areas
gave informed consent before participating.
Four additional cross-sectional studies
conducted by ATSDR during this time
period were not included in this analysis
because they did not include comparison
populations (ATSDR 1995a, 1996a) or did
not use questionnaires similar to those used
in the other studies (ATSDR 1994b, 1995c).
Environmental Health Perspectives • VOLUME 114 | NUMBER 7 | July 2006 1065
Research
Address correspondence to D.M. Williamson, Division
of Health Studies, ATSDR, 1600 Clifton Rd., MS
E-31, Atlanta, GA 30333 USA. Telephone: (404) 498-
0586. Fax: (404) 498-0077. E-mail: djw8@cdc.gov
We are grateful to WIT Press, Southampton,
United Kingdom, for their permission to reproduce
this material, which was ﬁrst published as a summary
in the Proceedings of the First International Conference
on Environmental Exposure and Health [Williamson
DM, White MC, Poole C, Kleinbaum D, Vogt R,
North K. 2005. Distribution of immunoglobulins A,
G and M among individuals living in communities
potentially exposed to low-level environmental expo-
sures. In: Proceedings of the First International
Conference on Environmental Exposure and Health.
6-7 October 2005, Atlanta, GA. Southampton,
UK:WIT Press. Available: http://library.witpress.
com/pages/listPapers.asp?q_bid=338 (accessed 29
May 2006)]. 
The findings and conclusions in this report are
those of the authors and do not necessarily represent
the views of the funding agencies. Use of trade names
is for identiﬁcation only and does not imply endorse-
ment by the Centers for Disease Control and
Prevention, the Agency for Toxic Substances and
Disease Registry, the U.S. Public Health Service, or
the U.S. Department of Health and Human Services.
The authors declare they have no competing
ﬁnancial interests.
Received 21 December 2005; accepted 30 March
2006.
Evaluation of Serum Immunoglobulins among Individuals Living Near 
Six Superfund Sites
Dhelia M. Williamson,1,2 Mary C. White,3 Charles Poole,2 David Kleinbaum,4 Robert Vogt,3 and Kari North2
1Division of Health Studies, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, USA; 2Department of Epidemiology,
University of North Carolina School of Public Health, Chapel Hill, North Carolina, USA; 3Centers for Disease Control and Prevention,
Atlanta, Georgia, USA; 4Department of Epidemiology, Emory University, Atlanta, Georgia, USA
Residents living in communities near Superfund sites have expressed concern that releases from
these facilities affect their health, including adverse effects on their immune systems. We used data
from six cross-sectional studies to evaluate whether people who live near several Superfund sites
are more likely to have individual immunoglobulin test results (IgA, IgG, and IgM) below or
above the reference range than those who live in comparison areas with no Superfund site. Study
participants consisted of target-area residents who lived close to a Superfund site and comparison-
area residents who were not located near any Superfund or hazardous waste sites. A consistent
modeling strategy was used across studies to assess the magnitude of the relationship between area
of residence and immunoglobulin test results, adjusting for potential confounders and effect mod-
iﬁers. In all study areas, the results suggest that people who live near a Superfund site may have
been more likely to have IgA test results above the reference range than comparison areas residents
regardless of modeling strategy employed. The effect measures were larger for residents who lived
in communities near military bases with groundwater contamination. For all analyses the wide
confidence intervals reflect uncertainty in the magnitude of these effects. To adequately address
the question of whether the immune system is affected by low-level exposures to hazardous sub-
stances, we recommend that more functional immunotoxicity tests be conducted in human popu-
lations where individual exposure information is available or when it can be reasonably estimated
from environmental exposure measurements. Key words: community concerns, environmental
exposures, immunoglobulin, Superfund. Environ Health Perspect 114:1065–1071 (2006).
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included randomly selected community resi-
dents. We conducted a census of each com-
munity to create the sampling frame. Target
area populations consisted of residents living
in well-defined areas located close to a
Superfund site. Participation rates ranged
from 48 to 86% across the six sites and were
generally higher among target area residents.
We selected each target area based on environ-
mental sampling data that identiﬁed contami-
nated soil, groundwater, surface water, or
sediment. Individual exposure data typically
were not available. We selected comparison
area communities on the basis of demograph-
ics and socioeconomic status similar to those
of the target area community. Some of the
socioeconomic factors considered were style
and age of housing, household income, and
degree of urbanization. The comparison areas
were > 5 miles from the sites of interest and
were not located near any other Superfund or
hazardous waste sites.
Data collection. We asked study partici-
pants to be interviewed and provide a blood
sample. The interview collected information
on sociodemographic characteristics (age, race,
sex, educational level, years of residence), his-
tory of chronic diseases (arthritis, rheumatism,
chronic bronchitis, asthma, cancer, multiple
sclerosis, lupus), history of speciﬁc symptoms
(skin rashes, eczema, asthma, bronchitis, aller-
gies), smoking status of the study participant
and other household residents, and rating of
general health (excellent, good, fair, poor). At
three of the study sites (Kentucky, Nebraska,
and North Carolina) we collected information
about sources of heat for the home (coal stove,
fireplace, kerosene or gas heater, or wood
stove) and occupational exposures to chemicals
(solvents, cleaning agents, dust, insulating
materials, paints, gasoline, or kerosene).
Determination of serum immuno-
globulins. Sera were separated by centrifuga-
tion at the phlebotomy site and shipped to
the Foundation for Blood Research in
Scarborough, Maine, where they were refrig-
erated and assayed within 3 working days.
The immunoglobulins measured corre-
sponded to those recommended in the test
battery (ATSDR 1994a), which did not
include IgE. We tested samples using the
immunoturbidimetry method previously
described (Hudson et al. 1987). Because of
variations among sex and age groups, refer-
ence distributions for IgA, IgG, and IgM
measurements are sex and age specific
(Ritchie et al. 1998).
Statistical analysis. We used polytomous
logistic regression to examine the relationship
between area of residence and immunoglobu-
lin test result. We used a three-category classiﬁ-
cation to code the immunoglobulin test results
into those above (> 97.5th percentile), within,
or below (< 2.5th percentile) the reference
range because increases and decreases of
immunoglobulins have been associated with
adverse health outcomes (Fischbach 2000).
SAS statistical software (version 9.0; SAS
Institute Inc., Cary, NC) was used for data
management and statistical analysis.
We analyzed the data from each of the six
studies using the same modeling strategies to
assess the magnitude of the relationship
between area of residence and immuno-
globulin test results, adjusting for factors that
may be potential confounders or modiﬁers of
these associations. The modeling strategies
included conducting the following ﬁve logistic
regression analyses: model 1, no adjustment
(crude); model 2, adjustment for sociodemo-
graphic variables only; model 3, adjustment
for sociodemographic variables and other
exposure information (i.e., smoking status of
study participant and other household resi-
dents; use of coal stove, ﬁreplace, kerosene or
gas heater, or wood stove as source of heat for
the home; and occupational exposure to
chemicals); model 4, adjustment for sociode-
mographic variables, other exposure informa-
tion, history of speciﬁc symptoms and illness,
and rating of general health; and model 5, a
backward elimination method described by
Kleinbaum (1994). To be included in the
regression analysis, studies had to have at least
10 individuals with immunoglobulin test
results either below or above the reference
range and at least three individuals in each the
target and comparison group.
Model 5 included assessing each of the six
studies individually using the following strategy.
First, interactions between the exposure variable
(residence in the target vs. comparison group)
and one covariate at a time were examined.
Factors that may affect immunologic assay
results were considered effect-measure modiﬁers
if the Breslow-Day p-value was < 0.5 (Breslow
and Day 1980). Next, those covariates not
found to be effect-measure modifiers were
assessed univariately as potential confounders. A
covariate was deemed a confounder if the
absolute value of the natural logarithm of the
ratio of the unadjusted to adjusted odds ratio
(OR) exceeded 0.10. All variables considered
effect-measure modiﬁers or confounders were
included in the full model. We assessed each
interaction term one at a time using the back-
ward elimination method to eliminate insigniﬁ-
cant variables from the model. We assessed
significance by comparing the change in log
likelihoods (α < 0.20).
Results
Descriptive characteristics. Most study partici-
pants from each study area were white, were
older than 30 years, and had attained at least a
high school education (Table 2). The Texas
study had a more diverse racial and ethnic
composition. Years of residence in the current
home varied considerably among the study
sites; all of the study participants in Nebraska
had lived in their residences for at least
10 years, whereas nearly all study participants
in Texas had lived in their residences for
< 10 years. Sample sizes of the six studies
ranged from 258 participants in the North
Carolina study to 912 participants in the
Massachusetts study.
Most study participants in both the target
and comparison groups for all six areas were in
good or excellent health; did not report having
a history of speciﬁc symptoms, illness, or aller-
gies; did not currently smoke; and did not live
in a household in which someone else smoked
(Table 3). Only in North Carolina did most
study participants report using a coal stove,
ﬁreplace, kerosene or gas heater, or wood stove
to heat their house. Most study participants in
Williamson et al.
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Table 1. ATSDR cross-sectional studies that included the standardized questionnaire and immune
biomarker panel, 1991–1994.
Study location Type of facility Exposure pathway Contaminants
McClellan Air Force Base, Aircraft maintenance Ambient air, sediment, Volatile organic compounds,
Sacramento, CA facility soil, groundwater heavy metals
Calvert City Industrial  Manufacturing and  Ambient air Heavy metals, volatile organic 
Complex, Calvert City, KY handling of chemical  compounds, mineral acids, 
compounds asbestos, dioxin, radioactive
substances, neurotoxic chemicals
Otis Air National Guard, Military training Groundwater Volatile organic compounds,
Falmouth, MA installation polychlorinated biphenyls,
polycyclic aromatic hydrocarbons
Cornhusker Army Production of artillery  Groundwater Explosives (RDX and TNT),
Ammunition Plant, shells, bombs, and  volatile organic compounds
Cornhusker, NE rockets
Caldwell Systems Inc., Hazardous waste Ambient air Incineration products,
Caldwell County, NC incinerator phthalates, volatile organic
compounds, chromium, arsenic
Brio Reﬁning Co. Inc., Regeneration of copper Groundwater Volatile organic compounds,
Harris County, TX catalysts, recovery of organic compounds
petrochemicals and
vinyl chloride
Abbreviations: RDX, royal demolition explosives (1,3,5-trinitro-1,3,5-triazine); TNT, trinitrotoluene.both Kentucky and North Carolina reported
having occupational exposure to chemicals.
The proportion of study participants who
had individual immunoglobulin test results
(IgA, IgG, and IgM) either below or above the
reference range varied by speciﬁc immunoglobu-
lin and study site (Table 4). Overall, the percent-
age of study participants in both target and
comparison groups with an immunoglobulin
test result above the reference range was gener-
ally higher than the percentage of study partici-
pants with an immunoglobulin test result
below the reference range.
Multivariate analyses. Tables 5–7 show the
ORs and 95% confidence intervals (CIs)
examining the relationship between area of
residence (target vs. comparison) and having
an immunoglobulin (IgA, IgG, IgM) test result
below or above the reference range in six geo-
graphic areas using the different modeling
strategies described above. Results from the
backward elimination modeling strategy
(model 5), which included interaction terms,
are discussed individually.
Immunoglobulin A. Results below the ref-
erence range. Target area residents in four
study areas (California, Kentucky, North
Carolina, and Texas) had an increased preva-
lence of having an IgA test result below the ref-
erence range compared with comparison area
residents, whereas target area residents in two
study areas (Massachusetts and Nebraska) had a
decreased prevalence of having an IgA test
result below the reference range (Table 5). OR
estimates for Texas fell on both sides of the
null, depending on which modeling strategy
was used. Data were too sparse for North
Carolina to generate adjusted OR estimates. All
estimates were imprecise [upper-to-lower conﬁ-
dence limit ratio (CLR) > 4] (Poole 2001).
Using the backward elimination strategy
(model 5), the models for California and
Nebraska included interaction terms. In
California, the odds of women living in the
target area having an IgA test result below the
reference range were 2.66 times those of
women living in the comparison area. In con-
trast, the odds of males living in the target area
having an IgA test result below the reference
range were 1.16 times those of males living in
the comparison area. In Nebraska, individuals
who reported having allergies and who lived in
the target area were 1.29 times more likely to
have an IgA test result below the reference
range than those individuals who reported hav-
ing allergies and who lived in the comparison
area. Individuals who reported not having
allergies and who lived in the target area in
Nebraska were 0.23 times less likely to have an
IgA test result below the reference range than
those living in the comparison area who did
not report having allergies.
Results above the reference range. Target
area residents in all study areas except North
Carolina had an increased prevalence of having
IgA test results above the reference range than
comparison area residents (data were too sparse
for North Carolina to generate OR estimates).
Adjusted OR estimates for Texas fell on both
sides of the unadjusted estimate, depending on
which modeling strategy was used. All esti-
mates were imprecise (CLR > 4).
Using the backward elimination strategy
(model 5), two interaction terms were
included in the Massachusetts model. The
odds of women living in the target area hav-
ing an IgA test result above the reference
range were 11.3 times those of women living
in the comparison area, whereas the odds of
males living in the target area were 1.66 times
those living in the comparison area. For
smokers, the odds of having an IgA test result
above the reference range were 0.14 times
lower among those living in the target area
than among those living in the comparison
area, whereas nonsmokers were 1.66 times
more likely to have an IgA test result above
the reference range than nonsmokers living in
the comparison area.
Immunoglobulin G. Results below the ref-
erence range. Table 6 shows that target area
residents in Nebraska and Texas had an
increased prevalence of having an IgG test
result below the reference range compared with
comparison area residents, whereas target area
residents in Massachusetts had a decreased
Evaluation of immunoglobulins
Environmental Health Perspectives • VOLUME 114 | NUMBER 7 | July 2006 1067
Table 2. Demographic characteristics of study participants from six cross-sectional studies conducted by ATSDR, 1991–1994 [n (%)].
California (n = 655) Kentucky (n = 720) Massachusetts (n = 912) Nebraska (n = 597) North Carolina (n = 258) Texas (n = 774)
Target Comp Target Comp Target Comp Target Comp Target Comp Target Comp
Characteristic (n = 453) (n = 202) (n = 357) (n = 363) (n = 605) (n = 307) (n = 297) (n = 300) (n = 164) (n = 94) (n = 414) (n = 360)
Age
< 10 11 (2) 8 (4) 11 (3) 12 (3) 20 (3) 10 (3) 0 (0) 0 (0) 0 (0) 0 (0) 17 (4) 17 (5)
10–19 123 (27) 50 (25) 62 (17) 73 (20) 125 (21) 67 (22) 77 (26) 61 (20) 12 (7) 2 (2) 77 (19) 89 (25)
20–29 54 (12) 19 (9) 43 (12) 37 (10) 45 (7) 15 (5) 19 (6) 6 (2) 24 (15) 9 (10) 58 (14) 55 (15)
30–39 64 (14) 36 (18) 65 (18) 70 (19) 118 (20) 59 (19) 12 (4) 21 (7) 20 (12) 12 (13) 147 (36) 128 (36)
40–49 69 (15) 33 (16) 60 (17) 54 (15) 114 (19) 61 (20) 76 (26) 70 (23) 44 (27) 29 (31) 61 (15) 43 (12)
50–59 58 (13) 20 (10) 46 (13) 51 (14) 76 (13) 39 (13) 66 (22) 74 (25) 32 (20) 23 (24) 41 (10) 15 (4)
≥ 60 74 (16) 36 (18) 70 (20) 66 (18) 107 (18) 56 (18) 47 (16) 68 (23) 32 (20) 19 (20) 13 (3) 13 (4)
Sex
Male 219 (48) 102 (50) 168 (47) 180 (50) 290 (48) 147 (48) 152 (51) 144 (48) 76 (46) 42 (45) 203 (49) 176 (49)
Female 234 (52) 100 (50) 189 (53) 183 (50) 315 (52) 160 (52) 145 (49) 156 (52) 88 (54) 52 (55) 211 (51) 184 (51)
Race
White 385 (85) 182 (90) 353 (99) 361 (99) 576 (95) 296 (96) 287 (97) 297 (99) 164 (100) 94 (100) 241 (58) 214 (59)
African American 19 (4) 3 (1) 1 (< 1) 0 (0) 8 (1) 2 (1) 1 (< 1) 1 (< 1) 0 (0) 0 (0) 54 (13) 48 (13)
Other 49 (11) 16 (8) 2 (1) 2 (1) 20 (3) 9 (3) 7 (2) 2 (1) 0 (0) 0 (0) 78 (19) 79 (22)
Unknown/missing 0 (0) 1 (< 1) 1 (< 1) 0 (0) 1 (< 1) 0 (0) 2 (< 1) 0 (0) 0 (0) 0 (0) 41 (10) 19 (5)
Hispanic ethnicity
Yes 67 (15) 30 (15) 5 (1) 5 (1) 10 (2) 2 (1) 3 (1) 10 (3) 0 (0) 0 (0) 65 (16) 81 (23)
No 381 (84) 172 (85) 346 (97) 357 (98) 592 (98) 304 (99) 293 (99) 289 (96) 0 (0) 0 (0) 346 (84) 267 (74)
Missing 5 (1) 0 (0) 6 (2) 1 (< 1) 3 (< 1) 1 (< 1) 1 (< 1) 1 (< 1) 164 (100) 94 (100) 3 (1) 12 (3)
Education
< High school 205 (45) 79 (39) 107 (30) 121 (33) 154 (25) 75 (24) 81 (27) 75 (25) 60 (37) 25 (27) 115 (28) 133 (37)
High school 109 (24) 55 (27) 128 (36) 128 (35) 289 (48) 149 (49) 122 (41) 106 (35) 45 (27) 31 (33) 200 (48) 166 (46)
> High school 139 (31) 68 (34) 121 (34) 114 (31) 162 (27) 83 (27) 94 (32) 119 (40) 59 (36) 38 (40) 98 (24) 61 (17)
Unknown/missing 0 (0) 0 (0) 1 (< 1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (< 1) 0 (0)
Years in residence
< 5 102 (23) 95 (47) 117 (33) 136 (37) 74 (12) 32 (10) 0 (0) 0 (0) 26 (16) 10 (11) 252 (61) 210 (58)
5–10 91 (20) 44 (22) 90 (25) 79 (22) 197 (33) 111 (36) 0 (0) 0 (0) 34 (21) 21 (22) 137 (33) 110 (31)
10–19 161 (36) 36 (18) 84 (24) 90 (25) 274 (45) 139 (45) 247 (83) 189 (63) 54 (33) 30 (32) 25 (6) 40 (11)
≥ 20 99 (22) 27 (13) 66 (18) 58 (16) 60 (10) 25 (8) 50 (17) 111 (37) 50 (30) 33 (35) 0 (0) 0 (0)
Comp, comparison group.prevalence. Data were too sparse in California,
Kentucky, and North Carolina to generate OR
estimates. Using the backward elimination
strategy (model 5), the OR for Texas was sub-
stantially lower than the estimates generated
from the other models. All estimates were
imprecise (CLR ≥ 4).
Results above the reference range. When
examining the relationship between area of
residence and having an IgG test result above
the reference range, target area residents in four
study areas (Kentucky, Massachusetts,
Nebraska, and Texas) had an increased preva-
lence of IgG test results above the reference
range compared with comparison area resi-
dents, whereas target area residents in one area
(California) had a decreased prevalence. Data
were too sparse for North Carolina to generate
OR estimates. In Massachusetts, adjustment
for additional covariates resulted in the OR
estimates falling on the opposite side of the
null from the unadjusted OR. In Nebraska,
the OR generated from model 4 was approxi-
mately the null value. All OR estimates were
imprecise (CLR ≥ 4).
Immunoglobulin M. Results below the
reference range. None of the six studies had a
total of 10 individuals with IgM test results
below the reference range or had at least three
individuals in both the target and comparison
areas, so no analyses were conducted (Table 7).
Results above the reference range.
Table 7 shows that target area residents in two
study areas (Kentucky and North Carolina)
had a modest increased prevalence of having
IgM test results above the reference range
compared with comparison area residents,
whereas target area residents in three study
areas (California, Massachusetts, and Texas)
had a decreased prevalence. The OR estimates
for Nebraska fell on both sides of the null
depending on which modeling strategy was
used. Data were too sparse for North Carolina
to generate adjusted OR estimates. All esti-
mates were imprecise (CLR ≥ 4).
Discussion
Evidence from both human and animal stud-
ies suggests that a variety of chemicals, includ-
ing volatile organic compounds and metals,
are able to adversely affect the immune system
(ATSDR 1994a, 1998b; Burns 1996;
National Research Council 1992; Snyder
1994). Xenobiotic toxicants have been shown
to either augment the normal immune
response, resulting in hypersensitivity, or sup-
press the immune responses, resulting in
immune deficiency. The consequences of
immunosuppression may include respiratory
infections, opportunistic infections, and can-
cer (Descotes and Choquet-Kastylevsky
2001). The consequences of immunoenhance-
ment are less well established but include
inﬂuenza-like reactions such as chills, malaise,
and hypotension, as well as exacerbation of
chronic infections, psoriasis, Crohn disease,
and autoimmune diseases (Descotes and
Choquet-Kastylevsky 2001).
Because of the development of standard-
ized reference ranges for IgA, IgG, and IgM,
we were able to explore a question that is often
raised but rarely investigated: whether individ-
uals living near Superfund sites are more likely
to experience changes in immune status than
individuals living in areas with no nearby
Williamson et al.
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Table 3. Self-reported symptoms and illnesses, responses to subjective questions, and other exposure information from six cross-sectional studies conducted by
ATSDR 1991–1994 [n (%)].
California (n = 655) Kentucky (n = 720) Massachusetts (n = 912) Nebraska (n = 597) North Carolina (n = 258) Texas (n = 774)
Target Comp Target Comp Target Comp Target Comp Target Comp Target Comp
Characteristic (n = 453) (n = 202) (n = 357) (n = 363) (n = 605) (n = 307) (n = 297) (n = 300) (n = 164) (n = 94) (n = 414) (n = 360)
Symptoms/Illnesses
Eczema or skin rashesa
Yes 103 (23) 29 (14) 36 (10) 43 (12) 86 (14) 43 (14) 49 (16) 38 (13) 35 (21) 19 (20) 114 (28) 44 (12)
No 350 (77) 173 (86) 321 (90) 320 (88) 519 (86) 264 (86) 248 (84) 262 (87) 129 (79) 75 (80) 300 (72) 316 (88)
Asthma or bronchitisa
Yes 23 (5) 6 (3) 11 (3) 11 (3) 12 (2) 6 (2) 10 (3) 7 (2) 23 (14) 4 (4) 12 (3) 5 (1)
No 430 (95) 196 (97) 346 (97) 352 (97) 593 (98) 301 (98) 287 (97) 293 (98) 141 (86) 90 (96) 402 (97) 355 (99)
Allergyc
Yes 220 (49) 71 (35) 104 (29) 104 (29) 204 (34) 81 (26) 119 (40) 100 (33) 86 (52) 43 (46) 164 (40) 83 (23)
No 233 (51) 131 (65) 253 (71) 259 (71) 401 (66) 226 (74) 178 (60) 200 (67) 78 (48) 51 (54) 250 (60) 277 (77)
Cancer/immune systemc
Yes 61 (13) 22 (11) 36 (10) 43 (12) 86 (14) 43 (14) 49 (16) 38 (13) 41 (25) 22 (23) 35 (8) 14 (4)
No 392 (87) 180 (89) 321 (90) 320 (88) 519 (86) 264 (86) 248 (84) 262 (87) 123 (75) 72 (77) 379 (92) 346 (96)
Other Information
Overall health
Excellent 100 (22) 61 (30) 114 (32) 110 (30) 260 (43) 142 (46) 107 (36) 106 (35) 15 (9) 12 (13) 109 (26) 116 (32)
Good 230 (51) 104 (51) 190 (53) 210 (58) 300 (50) 141 (46) 166 (56) 173 (58) 92 (56) 63 (67) 244 (59) 181 (50)
Fair 101 (22) 31 (15) 45 (13) 39 (11) 40 (7) 21 (7) 23 (8) 20 (7) 47 (29) 16 (17) 58 (14) 61 (17)
Poor 22 (5) 6 (3) 7 (2) 4 (1) 4 (< 1) 3 (1) 1 (< 1) 1 (< 1) 10 (6) 3 (3) 2 (< 1) 2 (1)
Missing 0 (0) 0 (0) 1 (< 1) 0 (0) 1 (< 1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (< 1) 0 (0)
Heat homed
Yes NA NA 110 (31) 120 (33) NA NA 116 (39) 64 (21) 95 (58) 51 (54) NA NA
No 247 (69) 243 (67) 181 (61) 236 (79) 69 (42) 43 (46)
Occupational exposuree
Yes NA NA 184 (52) 210 (58) NA NA 136 (46) 116 (39) 117 (71) 57 (61) NA NA
No 173 (48) 153 (42) 161 (54) 184 (61) 47 (29) 37 (39)
Currently smoke
Yes 102 (23) 40 (20) 89 (25) 100 (28) 101 (17) 61 (20) 41 (14) 47 (16) 54 (33) 27 (29) 80 (19) 37 (10)
No 309 (68) 134 (66) 242 (68) 232 (64) 453 (75) 220 (72) 249 (84) 245 (82) 110 (67) 67 (71) 330 (80) 321 (89)
Missing 42 (9) 28 (14) 26 (7) 31 (8) 51 (8) 26 (8) 7 (2) 8 (2) 0 (0) 0 (0) 4 (1) 2 (1)
Someone smoke in house
Yes 134 (30) 54 (27) 100 (28) 117 (32) 130 (21) 69 (22) 62 (21) 77 (26) 56 (34) 24 (26) 117 (28) 88 (24)
No 277 (61) 120 (59) 230 (64) 215 (59) 424 (70) 213 (69) 228 (77) 215 (72) 108 (66) 70 (74) 295 (71) 269 (75)
Missing 42 (9) 28 (14) 27 (8) 31 (9) 51 (8) 25 (8) 7 (2) 8 (2) 0 (0) 0 (0) 2 (1) 3 (1)
Abbreviations: Comp, comparison group; NA, not applicable. 
aOnset since moving to current home. bIncludes allergy, hay fever, watery and burning eyes, irritated nose, severe headaches; onset since moving to current home. cIncludes all cancer
types, lupus, osteoarthritis, multiple sclerosis, etc. dUse of coal stove, ﬁreplace, kerosene or gas heater, or wood stove to heat house. eOccupational exposures to solvents, cleaning
agents, dust, insulating materials, paints, gasoline, or kerosene.Evaluation of immunoglobulins
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Superfund sites. We examined immunoglobu-
lin test results from six cross-sectional studies
conducted in different geographic areas using
standardized reference ranges and consistent
modeling strategies. Our results suggest that
there is variability among the OR estimates
generated when examining the relationship
between area of residence and having an
immunoglobulin test result below or above
the reference range. The only consistent pat-
tern observed in all study areas was that indi-
viduals who live near a Superfund site were
more likely to have IgA test results above the
reference range than comparison area residents
regardless of modeling strategy employed.
However, the wide CI values reflect large
uncertainty in the magnitude of these effects.
The effect measures for IgA were consis-
tently larger (OR > 1.5) for residents who lived
in communities in Massachusetts and
Nebraska near military bases with only
groundwater contamination. Although the
estimates were imprecise, our results also sug-
gest that individuals living closer to these mili-
tary bases were less likely to have IgA test
results below the reference range than individ-
uals who lived in the comparison neighbor-
hood. In addition, residents who lived near an
industrial complex in Kentucky with potential
ambient air exposure to heavy metals and other
chemicals were more likely to have IgG test
results above the reference range than compari-
son area residents. Because the reference ranges
used for this analysis were age and sex adjusted,
the observed variability in immunoglobulin
results is unlikely to be due to residual con-
founding by age and sex.
Previous studies have also shown increased
IgA levels among individuals living near
Superfund sites. ATSDR examined the associ-
ation between biologic markers of immune
system impairment and environmental expo-
sure to cadmium and lead among children and
adults living in communities contaminated by
mining and smelting operations at four
Superfund sites (Sarasua et al. 2000). For chil-
dren 6–35 months of age, an association was
found between increased blood lead levels and
increased serum IgA, IgG, and IgM. In adults,
urine cadmium was associated with higher lev-
els of IgA after adjustment for age, sex, and
Table 4. Serum immunoglobulin results from six cross-sectional studies conducted by ATSDR 1991–1994 [n (%)].
California (n = 655) Kentucky (n = 720) Massachusetts (n = 912) Nebraska (n = 597) North Carolina (n = 258) Texas (n = 774)
Target Comp Target Comp Target Comp Target Comp Target Comp Target Comp
Characteristic (n = 453) (n = 202) (n = 357) (n = 363) (n = 605) (n = 307) (n = 297) (n = 300) (n = 164) (n = 94) (n = 414) (n = 360)
IgA
Below 11 (2) 3 (1) 13 (4) 8 (2) 14 (2) 9 (3) 7 (2) 14 (5) 11 (7) 5 (5) 8 (2) 5 (1)
Within 420 (93) 191 (95) 333 (93) 346 (95) 558 (92) 282 (92) 281 (95) 279 (93) 143 (87) 85 (90) 379 (92) 326 (91)
Above 17 (4) 7 (3) 11 (3) 9 (2) 25 (4) 5 (2) 9 (3) 5 (2) 4 (2) 4 (4) 16 (4) 10 (3)
Missing 5 (1) 1 (< 1) 0 (0) 0 (0) 8 (1) 11 (4) 0 (0) 2 (< 1) 6 (4) 0 (0) 11 (3) 19 (5)
IgG
Below 2 (< 1) 4 (2) 5 (1) 3 (1) 11 (2) 14 (5) 9 (3) 6 (2) 4 (2) 1 (1) 7 (2) 5 (1)
Within 433 (96) 185 (92) 342 (96) 356 (98) 571 (94) 276 (90) 282 (95) 287 (96) 150 (92) 93 (99) 368 (89) 321 (89)
Above 13 (3) 12 (6) 10 (3) 4 (1) 15 (2) 6 (2) 6 (2) 5 (2) 4 (2) 0 (0) 28 (7) 15 (4)
Missing 5 (1) 1 (< 1) 0 (0) 0 (0) 8 (1) 11 (4) 0 (0) 2 (< 1) 6 (4) 0 (0) 11 (3) 19 (5)
IgM
Below 1 (< 1) 3 (1) 3 (1) 3 (1) 6 (1) 1 (< 1) 6 (2) 3 (1) 0 (0) 2 (2) 10 (2) 2 (1)
Within 432 (95) 188 (93) 342 (96) 350 (96) 567 (94) 282 (92) 278 (94) 282 (94) 149 (91) 88 (94) 380 (92) 320 (89)
Above 15 (3) 10 (5) 12 (3) 10 (3) 24 (4) 13 (4) 13 (4) 13 (4) 9 (5) 4 (4) 13 (3) 19 (5)
Missing 5 (1) 1 (< 1) 0 (0) 0 (0) 8 (1) 11 (4) 0 (0) 2 (< 1) 6 (4) 0 (0) 11 (3) 19 (5)
One or more
Below 11 (2) 8 (4) 18 (5) 12 (3) 24 (4) 19 (6) 18 (6) 18 (6) 12 (7) 7 (7) 24 (6) 10 (3)
Within 395 (87) 167 (83) 310 (87) 329 (91) 514 (85) 254 (83) 252 (85) 258 (86) 129 (79) 79 (84) 334 (81) 289 (80)
Above 42 (9) 26 (13) 29 (8) 22 (6) 59 (10) 23 (7) 27 (9) 22 (7) 17 (10) 8 (9) 45 (11) 42 (12)
Missing  5 (1) 1 (< 1) 0 (0) 0 (0) 8 (1) 11 (4) 0 (0) 2 (< 1) 6 (4) 0 (0) 11 (3) 19 (5)
Comp, comparison group.
Table 5. OR estimates (95% CIs) for area of residence and IgA test results for six ATSDR studies conducted 1991–1994.
Study area Model 1a Model 2b Model 3c Model 4d Model 5e
Results below the reference range
California 1.67 (0.46–6.05) 2.05 (0.54–7.88) 1.92 (0.48–7.68) 2.17 (0.52–9.09) 2.66 (0.52–13.51)f
1.16 (0.22–6.17)g
Kentucky 1.69 (0.69–4.13) 1.65 (0.67–4.08) 1.27 (0.49–3.28) 1.29 (0.49–3.37) 1.36 (0.54–3.44)
Massachusetts 0.79 (0.34–1.84) 0.80 (0.34–1.88) 0.65 (0.26–1.57) 0.65 (0.26–1.59) 0.63 (0.26–1.52)
Nebraska 0.50 (0.20–1.25) 0.60 (0.23–1.56) 0.58 (0.22–1.57) 0.59 (0.21–1.62) 1.29 (0.06–27.8)h
0.23 (0.05–1.11)i
North Carolina 1.31 (0.44–3.89) — — — —
Texas 1.38 (0.45–4.25) 0.98 (0.28–3.44) 1.15 (0.32–4.18) 0.83 (0.20–3.47) 1.16 (0.35–3.88)
Results above the reference range
California 1.10 (0.45–2.71) 1.35 (0.51–3.62) 1.32 (0.49–3.53) 1.22 (0.45–3.36) 1.17 (0.47–2.91)
Kentucky 1.27 (0.52–3.10) 1.21 (0.49–3.0) 1.13 (0.45–2.84) 1.27 (0.50–3.25) 1.22 (0.49–3.03)
Massachusetts 2.53 (0.96–6.67) 2.46 (0.92–6.54) 2.24 (0.83–6.01) 2.41 (0.88–6.63) 11.29 (0.11–145.53)f
1.66 (0.40–6.83)g
0.14 (0.0–4.52)j
1.66 (0.40–6.83)k
Nebraska 1.79 (0.59–5.40) 2.13 (0.58–7.77) 2.02 (0.54–7.61) 1.95 (0.46–8.21) 1.69 (0.56–5.15)
North Carolina — — — — —
Texas 1.38 (0.62–3.07) 1.23 (0.52–2.91) 1.32 (0.56–3.13) 1.71 (0.69–4.23) 1.62 (0.71–3.69)
—, OR estimates could not be calculated. 
aModel 1: unadjusted. bModel 2: adjusted for age, sex, race, Hispanic ethnicity, educational level, years in residence. cModel 3: adjusted for the model 2 covariates and other exposure
information. dModel 4: adjusted for the model 3 covariates, symptoms, illnesses, and overall health. eModel 5: adjusted using the backward elimination strategy of Kleinbaum (1994). fOR
for women. gOR for men. hOR for individuals with allergies. iOR for individuals without allergies. jOR for smokers. kOR for nonsmokers.other confounders. Additionally, researchers at
the University of North Carolina at Chapel
Hill examined the effects on the immune sys-
tem among residents living near the Pesticides
Dump Site in Aberdeen, North Carolina, who
were potentially exposed to 1,1-dichloro-2,2-
bis(p-chlorophenyl)ethylene (DDE). The
researchers found modestly increased mean
IgA levels with increased DDE levels (Vine
et al. 2001). Both these studies examined dif-
ferences in mean IgA levels because standard-
ized reference ranges for immunoglobulins
were not available.
The main strength of our study was the
unique nature of the data. We used question-
naire and biological data from nearly 4,000
individuals living in six different geographic
areas in the United States. The studies used
in this analysis were also standardized: they
were conducted by the same government
agency during a relatively short time period
and used the same study design, question-
naire, and immune biomarker test battery.
These similarities allowed us to examine pat-
terns of immunoglobulin test results using
standardized reference ranges across the
different study areas.
A major limitation of this study is the
lack of exposure characterization. Individual
exposure data were not available, so area of
residence was used as a surrogate of exposure.
Another limitation was the small number of
study participants in some locations, which
precluded our ability to have the statistical
power to measure stable effect estimates.
Also, the information used in this study
relied upon self-reported behaviors and risk
factors ascertained through interviewer-
administered questionnaires. Therefore, there
is the possibility of misclassification bias in
that people in the target area might have
been able to recall symptoms or illnesses to a
different extent than people in the compari-
son areas. This bias could have limited our
ability to adjust for these potential con-
founders in the multivariate models. A final
limitation is that serum immunoglobulins are
considered a fairly insensitive indicator of
immune functions
Because the immune system is a target for
adverse effects from exposure to hazardous sub-
stances, laboratory tests to measure immune
status were included in several ATSDR com-
munity health studies. It was thought that the
tests would provide quantification of effects
given that values outside established reference
ranges are generally associated with adverse
health outcomes. However, to adequately
address the question of whether the immune
system is affected by low-level exposures to
hazardous substances, we recommend that
more functional immunotoxicity tests be con-
ducted in communities located near hazardous
waste sites when adequate sample size and indi-
vidual exposure information are available or
when they can be reasonably estimated from
environmental exposure measurements. Tests
of immune status could be included in such
studies but should be tailored for specific
types of contaminants or health end points.
IgE should be included in the immune status
tests because individuals with allergic diseases
have been shown to exhibit increased IgE lev-
els whereas decreased levels of IgE are found
in cases of autoimmune and other diseases.
Information regarding potential confounders
should be collected through questionnaires or
other mechanisms. Finally, the use of a single
reference laboratory would be ideal for qual-
ity control and for comparison of results
across studies.
Williamson et al.
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Table 6. OR estimates (95% CIs) for area of residence and IgG test results for six ATSDR studies conducted 1991–1994.
Study area Model 1a Model 2b Model 3c Model 4d Model 5e
Results below the reference range
California — — — — —
Kentucky — — — — —
Massachusetts 0.38 (0.17–0.85) 0.38 (0.17–0.86) 0.40 (0.17–0.94) 0.44 (0.18–1.06) 0.43 (0.18–1.01)
Nebraska 1.53 (0.54–4.34) 1.43 (0.49–4.21) 1.35 (0.44–4.17) 1.31 (0.42–4.13) 1.68 (0.58–4.85)
North Carolina — — — — —
Texas 1.22 (0.38–3.89) 1.83 (0.41–8.08) 1.79 (0.38–8.53) 1.68 (0.27–10.44) 1.03 (0.28–3.80)
Results above the reference range
California 0.46 (0.21–1.03) 0.38 (0.16–2.13) 0.38 (0.15–0.96) 0.35 (0.14–0.90) 0.39 (0.16–0.94)
Kentucky 2.60 (0.81–8.38) 2.38 (0.70–8.06) 2.39 (0.70–8.16) 2.57 (0.73–9.07) 2.51 (0.78–8.11)
Massachusetts 1.21 (0.46–3.15) 0.92 (0.34–2.50) 0.72 (0.25–2.05) 0.74 (0.25–2.14) 0.90 (0.33–2.44)
Nebraska 1.22 (0.37–4.05) 1.26 (0.33–4.90) 1.36 (0.34–5.50) 1.02 (0.24–4.30) 1.38 (0.41–4.66)
North Carolina — — — — —
Texas 1.63 (0.85–3.10) 1.52 (0.72–3.20) 1.60 (0.75–3.41) 1.52 (0.66–3.49) 1.58 (0.82–3.04)
—, OR estimates could not be calculated. 
aModel 1: unadjusted. b Model 2: adjusted for age, sex, race, Hispanic ethnicity, educational level, years in residence. cModel 3: adjusted for the model 2 covariates and other exposure
information. dModel 4: adjusted for the model 3 covariates, symptoms, illnesses, and overall health. eModel 5: adjusted using the backward elimination strategy of Kleinbaum (1994).
Table 7. OR estimates (95% CIs) for area of residence and IgM test results for six ATSDR studies conducted 1991–1994.
Study area Model 1a Model 2b Model 3c Model 4d Model 5e
Results below the reference range
California — — — — —
Kentucky — — — — —
Massachusetts — — — — —
Nebraska — — — — —
North Carolina — — — — —
Texas — — — — —
Results above the reference range
California 0.65 (0.29–1.48) 0.66 (0.27–1.60) 0.60 (0.24–1.52) 0.60 (0.23–1.56) 0.67 (0.28–1.62)
Kentucky 1.23 (0.52–2.88) 1.21 (0.51–2.90) 1.23 (0.51–2.96) 1.19 (0.48–2.95) 1.18 (0.50–2.79)
Massachusetts 0.92 (0.46–1.83) 0.92 (0.45–1.89) 0.90 (0.44–1.87) 0.85 (0.41–1.76) 0.92 (0.46–1.84)
Nebraska 1.01 (0.46–2.23) 1.22 (0.52–2.84) 1.05 (0.44–2.51) 1.0 (0.42–2.41) 0.98 (0.44–2.17)
North Carolina 1.33 (0.40–4.44) — — — —
Texas 0.58 (0.28–1.19) 0.65 (0.30–1.43) 0.68 (0.31–1.51) 0.58 (0.25–1.38) 0.62 (0.29–1.34)
—, adjusted OR estimates could not be calculated. 
aModel 1: unadjusted. bModel 2: adjusted for age, sex, race, Hispanic ethnicity, educational level, years in residence. cModel 3: adjusted for the model 2 covariates and other exposure
information. dModel 4: adjusted for the model 3 covariates, symptoms, illnesses, and overall health. eModel 5: adjusted using the backward elimination strategy of Kleinbaum (1994).REFERENCES
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